Estelle T.
- Country
- France
- Department
- Oncology for pediatrics
Research Overview
- MetroWILMS-1906: Phase 1-2 trial evaluating metronomic chemotherapy in patients with relapsed or refractory Wilms tumor
- Phase 3 Non-Inferiority Trial of Vincristine, Actinomycin-D, and Doxorubicin Versus Vincristine, Carboplatin, and Etoposide in Stage IV Pediatric Renal Tumors
- Phase 3 Study of Busulfan, Melphalan, and Chemoimmunotherapy in High-Risk Neuroblastoma Patients with Insufficient Metastatic Response
Data & Insights
Has run more than one trial at 108 of 223 partner sites.
Specializations
Pediatric Solid Tumors
The investigator specializes in treating various types of pediatric solid tumors, with particular emphasis on hepatic malignancies including hepatoblastoma and hepatocellular carcinoma. Their research extends to bone tumors, specifically focusing on high-grade osteosarcoma.
- Hepatoblastoma
- Hepatocellular Carcinoma
- Osteosarcoma
Neurological Oncology
The investigator has extensive experience in treating neuroblastoma, with particular focus on high-risk and refractory cases. Their work encompasses both conventional treatments and innovative therapeutic approaches including peptide receptor radionuclide therapy.
- Refractory Neuroblastoma
- Recurrent Neuroblastoma
- High-Risk Neuroblastoma
Ophthalmic and Renal Oncology
The investigator focuses on the treatment of retinoblastoma using various conservative approaches and management of renal tumors. Their expertise includes both localized and metastatic disease states.
- Conservative Retinoblastoma Treatment
- Wilms Tumor
- Stage IV Renal Tumors
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.